HGH Fragment 176-191 vs L-692,429

Head-to-head comparison of HGH Fragment 176-191 (Human Growth Hormone Fragment 176-191) and L-692,429 (L-692,429) — benefits, dosing, side effects, research data, and where to buy.

PropertyHGH Fragment 176-191L-692,429
CategoryWeight ManagementGrowth Hormone
Full NameHuman Growth Hormone Fragment 176-191L-692,429
Molecular Weight1817.12 g/molN/A
Half-Life~30 minutesunknown / study-dependent
Amino Acids16N/A
Typical Dose0.03-0.1 mg/kg
RouteOral
Purity>98%≥98%
Studies Count4530
Research StatusActive ResearchPre-clinical

HGH Fragment 176-191 Benefits

  • Targeted fat loss, no blood sugar impact, no IGF-1 elevation, inhibits lipogenesis, stimulates lipolysis, improved body composition

L-692,429 Benefits

  • potent GHSR agonism
  • oral bioactivity in models
  • validates ghrelin pathway
  • useful research probe

HGH Fragment 176-191 Dosing

250-500 mcg subcutaneously 1-2 times daily on empty stomach. 12-16 week cycles typical in research.

L-692,429 Dosing

0.03-0.1 mg/kg in early studies|single oral or short-course research dosing|serial GH sampling recommended

HGH Fragment 176-191 Side Effects

  • Injection site irritation, headache, drowsiness. Does not affect blood sugar, insulin sensitivity, or elevate IGF-1.

L-692,429 Side Effects

  • increased appetite
  • glucose intolerance
  • transient prolactin changes

Research Overview

HGH Fragment 176-191

This 16-amino-acid fragment specifically targets adipose tissue via beta-3 adrenergic receptors. Works through a GH-receptor-independent pathway, explaining selective fat-loss properties without growth-promoting effects.

L-692,429

L-692,429 was important in early GH secretagogue research because it showed that nonpeptide molecules could trigger robust GH release. It remains a classic tool compound for studying receptor-mediated GH pulsatility and appetite signaling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

HGH Fragment 176-191 stacks with:

AOD-9604CJC-1295Ipamorelin

L-692,429 stacks with:

Receptor assaysEndocrine studies
fat-lossgrowth-hormone-fragmentlipolysisbody-recompositiontool-compoundgh-secretagogueghrelin-pathway